These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction. Marshall CJ; Nallaratnam M; Mocatta T; Smyth D; Richards M; Elliott JM; Blake J; Winterbourn CC; Kettle AJ; McClean DR Am J Cardiol; 2010 Aug; 106(3):316-22. PubMed ID: 20643239 [TBL] [Abstract][Full Text] [Related]
7. Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction. Dominguez-Rodriguez A; Abreu-Gonzalez P; Kaski JC Int J Cardiol; 2010 Oct; 144(3):407-9. PubMed ID: 19344969 [TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353 [TBL] [Abstract][Full Text] [Related]
9. Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation? d'Onofrio G; Mancini R; Vallone R; Alfano G; Candido A; Palla M; Mango G Blood Cells; 1983; 9(3):455-66. PubMed ID: 6326898 [TBL] [Abstract][Full Text] [Related]
10. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity. Kitahara M; Simonian Y; Eyre HJ J Lab Clin Med; 1979 Feb; 93(2):232-7. PubMed ID: 219116 [TBL] [Abstract][Full Text] [Related]
12. [Myeloperoxidase deficiency as a cause of recurrent infections]. Kusenbach G; Rister M Klin Padiatr; 1985; 197(5):443-5. PubMed ID: 2999502 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis. Wang W; Jian Z; Guo J; Ning X Life Sci; 2014 Nov; 117(1):19-23. PubMed ID: 25261597 [TBL] [Abstract][Full Text] [Related]
15. The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women. Zotova E; Lyrenäs L; de Faire U; Morgenstern R; Gigante B; Bennet AM Coron Artery Dis; 2009 Aug; 20(5):322-6. PubMed ID: 19543083 [TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. Stendahl O; Coble BI; Dahlgren C; Hed J; Molin L J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554 [TBL] [Abstract][Full Text] [Related]
17. The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk. Penn MS; Yenikomshian MA; Cummings AK; Klemes A; Damron JM; Purvis S; Beidelschies M; Birnbaum HG J Med Econ; 2015; 18(7):483-91. PubMed ID: 25763924 [TBL] [Abstract][Full Text] [Related]
18. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome. Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908 [TBL] [Abstract][Full Text] [Related]